{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [["Gynecologic tumors", "integrative and complementary medicine", "pelvic radiotherapy", "prostate cancer", "rectal bleeding", "side effects", "toxicity"]], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "23102757", "DateCompleted": {"Year": "2014", "Month": "01", "Day": "24"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "17"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1016/j.jpainsymman.2012.06.017", "S0885-3924(12)00402-2"], "ArticleDate": [{"Year": "2012", "Month": "10", "Day": "26"}], "Journal": {"ISSN": "1873-6513", "JournalIssue": {"Volume": "46", "Issue": "1", "PubDate": {"Year": "2013", "Month": "Jul"}}, "Title": "Journal of pain and symptom management", "ISOAbbreviation": "J Pain Symptom Manage"}, "ArticleTitle": "Long-term control of refractory hemorrhagic radiation proctitis with ozone therapy.", "Pagination": {"StartPage": "106", "EndPage": "112", "MedlinePgn": "106-12"}, "Abstract": {"AbstractText": ["Persistent or severe hemorrhagic radiation proctitis (HRP) has limited therapeutic options.", "To describe our experience with ozone therapy (O3T) in the management of refractory HRP.", "Patients (n=17; median age 69 years [range 42-80 years]) previously irradiated for prostate or uterine cancer and suffering persistent or severe HRP without response to conventional treatment were enrolled to receive an O3/O2 gas mixture via rectal insufflations and topical application of ozonized oil. Most of the patients (83%) had Grade 3 or Grade 4 toxicity. Median follow-up post-O3T was 40 months (range 3-56 months).", "Endoscopic treatments required were: 43 (median 1; range 0-10) pre-O3T; 17 (median 0; range 0-8; P=0.063) during O3T; and five (median 0; range 0-2; P=0.008) during follow-up. Hemoglobin levels were 10.35g/dL (7-14g/dL) pre-O3T and 13g/dL (9-15g/dL) (P=0.001) post-O3T. Median toxicity grades were 3 (range 2-4) pre-O3T, 1 (range 0-2; P<0.001) at the end of O3T, and 0 (range 0-1; P<0.001) at the last follow-up.", "Persistent advanced HRP was significantly improved with O3T. The addition of O3T can be useful as a complementary treatment in the long-term management of HRP and, as such, merits further evaluation."], "CopyrightInformation": "Copyright \u00a9 2013 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved."}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Radiation Oncology Department, Dr. Negrin University Hospital, Las Palmas, Spain. bernardinoclavo@gmail.com"}], "Identifier": [], "LastName": "Clavo", "ForeName": "Bernardino", "Initials": "B"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ceballos", "ForeName": "Daniel", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gutierrez", "ForeName": "Dominga", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Rovira", "ForeName": "Gloria", "Initials": "G"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Suarez", "ForeName": "Gerardo", "Initials": "G"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lopez", "ForeName": "Laura", "Initials": "L"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Pinar", "ForeName": "Beatriz", "Initials": "B"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Cabezon", "ForeName": "Auxiliadora", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Morales", "ForeName": "Victoria", "Initials": "V"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Oliva", "ForeName": "Elena", "Initials": "E"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Fiuza", "ForeName": "Dolores", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Santana-Rodriguez", "ForeName": "Norberto", "Initials": "N"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Pain Symptom Manage", "NlmUniqueID": "8605836", "ISSNLinking": "0885-3924"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Aged, 80 and over"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["etiology", "therapy"], "DescriptorName": "Gastrointestinal Hemorrhage"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": ["etiology", "therapy"], "DescriptorName": "Proctitis"}, {"QualifierName": ["radiotherapy"], "DescriptorName": "Prostatic Neoplasms"}, {"QualifierName": ["therapy"], "DescriptorName": "Radiation Injuries"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Radiotherapy"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}, {"QualifierName": ["radiotherapy"], "DescriptorName": "Uterine Neoplasms"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2012", "Month": "3", "Day": "14"}, {"Year": "2012", "Month": "6", "Day": "21"}, {"Year": "2012", "Month": "7", "Day": "1"}, {"Year": "2012", "Month": "10", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2012", "Month": "10", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2014", "Month": "1", "Day": "25", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["23102757", "10.1016/j.jpainsymman.2012.06.017", "S0885-3924(12)00402-2"]}}], "PubmedBookArticle": []}